Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (241) 241
Book Chapter (8) 8
Book Review (5) 5
Magazine Article (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (126) 126
life sciences & biomedicine (122) 122
ophthalmology (113) 113
humans (100) 100
female (67) 67
male (63) 63
middle aged (55) 55
aged (47) 47
intravitreal injections (39) 39
diabetic retinopathy (36) 36
retina (34) 34
vascular endothelial growth factor a - antagonists & inhibitors (33) 33
diabetes (32) 32
angiogenesis inhibitors - therapeutic use (31) 31
abridged index medicus (28) 28
edema (28) 28
vascular endothelial growth factor (28) 28
adult (27) 27
aged, 80 and over (27) 27
surgery (27) 27
visual acuity (24) 24
visual acuity - physiology (24) 24
prospective studies (23) 23
macular degeneration (22) 22
tomography, optical coherence (22) 22
clinical trials (21) 21
retrospective studies (20) 20
analysis (18) 18
diabetic retinopathy - drug therapy (18) 18
follow-up studies (18) 18
macular edema - drug therapy (18) 18
treatment outcome (18) 18
biological and medical sciences (17) 17
fluorescein angiography (17) 17
medical imaging (17) 17
medical sciences (16) 16
ranibizumab - therapeutic use (15) 15
diabetic retinopathy - diagnosis (13) 13
ranibizumab (13) 13
eye diseases (12) 12
macular edema - diagnosis (12) 12
patients (12) 12
recombinant fusion proteins - therapeutic use (12) 12
wet macular degeneration - drug therapy (12) 12
age (11) 11
consulting services (11) 11
diabetic retinopathy - physiopathology (11) 11
eye (11) 11
macular edema - physiopathology (11) 11
oncology (11) 11
receptors, vascular endothelial growth factor - therapeutic use (11) 11
tomography, optical coherence - methods (11) 11
angiogenesis inhibitors - administration & dosage (10) 10
care and treatment (10) 10
lasers (10) 10
research (10) 10
disease progression (9) 9
fluorescein angiography - methods (9) 9
retina - pathology (9) 9
risk factors (9) 9
studies (9) 9
time factors (9) 9
dropsy (8) 8
fundus oculi (8) 8
macula lutea - pathology (8) 8
macular edema - etiology (8) 8
medical research (8) 8
retinal vessels - pathology (8) 8
tomography (8) 8
tumors (8) 8
vitrectomy (8) 8
acuity (7) 7
angiography (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
carbonic anhydrase ix (7) 7
cell hypoxia (7) 7
diabetes mellitus (7) 7
drug dosages (7) 7
drug therapy (7) 7
endophthalmitis - microbiology (7) 7
hypoxia (7) 7
hypoxia-inducible factor 1, alpha subunit (7) 7
laser coagulation (7) 7
medical colleges (7) 7
necrosis (7) 7
neoplasm proteins - metabolism (7) 7
physiological aspects (7) 7
ranibizumab - administration & dosage (7) 7
retinal vein occlusion - drug therapy (7) 7
tumor cells, cultured (7) 7
wet macular degeneration - diagnosis (7) 7
angiogenesis inhibitors - adverse effects (6) 6
animals (6) 6
diabetic retinopathy - complications (6) 6
endophthalmitis (6) 6
gene expression (6) 6
hypoxia-inducible factor 1 (6) 6
ischemia - physiopathology (6) 6
macular edema - therapy (6) 6
medicine, experimental (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Diabetic retinopathy: A position statement by the American Diabetes Association
by Solomon, Sharon D and Chew, Emily and Duh, Elia J and Sobrin, Lucia and Sun, Jennifer K and VanderBeek, Brian L and Wykoff, Charles C and Gardner, Thomas W
Diabetes care, ISSN 0149-5992, 03/2017, Volume 40, Issue 3, pp. 412 - 418
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetic retinopathy | Diabetes | Medical diagnosis | Associations | Medical treatment | Position Statement
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes
by Witkin, Andre J and Chang, David F and Jumper, J. Michael and Charles, Steve and Eliott, Dean and Hoffman, Richard S and Mamalis, Nick and Miller, Kevin M and Wykoff, Charles C
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 05/2017, Volume 124, Issue 5, pp. 583 - 595
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Retina - drug effects | Intravitreal Injections - adverse effects | Vancomycin - administration & dosage | Tomography, Optical Coherence | Humans | Middle Aged | Male | Retinal Vasculitis - chemically induced | Surgical Wound Infection - prevention & control | Vancomycin - adverse effects | Retinal Hemorrhage - diagnosis | Retinal Hemorrhage - chemically induced | Retinal Vasculitis - diagnosis | Cataract Extraction - adverse effects | Aged, 80 and over | Female | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Fundus Oculi | Retina - pathology | Fluorescein Angiography | Vasculitis | Vancomycin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)
by Wykoff, Charles C and Brown, David M and Maldonado, Maria E and Croft, Daniel E
British journal of ophthalmology, ISSN 0007-1161, 07/2014, Volume 98, Issue 7, pp. 951 - 955
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Single-Blind Method | Prospective Studies | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity - drug effects | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Tomography, Optical Coherence | Treatment Outcome | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Subretinal Fluid | Aged | Receptors, Vascular Endothelial Growth Factor - adverse effects | Exudates and Transudates | Macular degeneration | Research | Drug therapy | Patient outcomes | Diabetic retinopathy | Vascular endothelial growth factor | Drug dosages | Age | Iodine | Index Medicus | Neovascularisation | Macula | Clinical Science | Clinical Trial | Retina | Degeneration | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases
by Ou, William C and Brown, David M and Payne, John F and Wykoff, Charles C
American journal of ophthalmology, ISSN 0002-9394, 2017, Volume 180, pp. 8 - 17
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Diabetic Retinopathy - drug therapy | Prospective Studies | Intravitreal Injections | Humans | Middle Aged | Male | Wet Macular Degeneration - physiopathology | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - physiopathology | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Retrospective Studies | Visual Acuity - physiology | Retinal Vein Occlusion - physiopathology | Tomography, Optical Coherence | Clinical Trials as Topic | Retina - diagnostic imaging | Wet Macular Degeneration - drug therapy | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Retinal Diseases - drug therapy | Retinal Diseases - physiopathology | Retina - pathology | Macular degeneration | Diabetic retinopathy | Medical colleges | Medical research | Care and treatment | Endothelial growth factors | Analysis | Medicine, Experimental | Studies | Company reports | Edema | Medical imaging | Clinical trials | Diabetes | Vascular endothelial growth factor | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Noncompliance in Prospective Retina Clinical Trials: Analysis of Factors Predicting Loss to Follow-up
by Zhou, Brenda and Mitchell, Travis C and Rusakevich, Alexander M and Brown, David M and Wykoff, Charles C
American journal of ophthalmology, ISSN 0002-9394, 02/2020, Volume 210, pp. 86 - 96
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Patient Dropouts - statistics & numerical data | Regression Analysis | Prospective Studies | Humans | Retinal Diseases - therapy | Patient Compliance - statistics & numerical data | Randomized Controlled Trials as Topic | Macular degeneration | Medicine, Experimental | Diabetic retinopathy | Medical research | Risk factors | Enrollments | Comorbidity | Clinical trials | Retina | Family medical history | Patient compliance | Variables | Human subjects | Demographics | Side effects | Employment | Diabetes | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Intravitreal aflibercept for proliferative diabetic retinopathy
by Brown, David M and Wykoff, Charles C
The Lancet (British edition), ISSN 0140-6736, 11/2017, Volume 390, Issue 10108, pp. 2141 - 2141
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Receptors, Vascular Endothelial Growth Factor | Vascular Endothelial Growth Factor A | Humans | Angiogenesis Inhibitors | Recombinant Fusion Proteins | Bevacizumab | Diabetic Retinopathy | Edema | Diabetic retinopathy | Retinopathy | Diabetes | Vascular endothelial growth factor | Diabetes mellitus | Retina | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Looking ahead in retinal disease management: highlights of the 2019 angiogenesis, exudation and degeneration symposium
by Puliafito, Carmen A and Wykoff, Charles C
International journal of retina and vitreous, ISSN 2056-9920, 2019, Volume 5, Issue 1, pp. 22 - 22
Diabetic retinopathy | Edema | Medical imaging | Gene expression | Macular degeneration | Atrophy | Angiogenesis | Tomography | Diabetes | Gene therapy | Vascular endothelial growth factor | Drug dosages | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis
by Witkin, Andre J., MD and Chang, David F., MD and Jumper, J. Michael, MD and Charles, Steve, MD, FACS and Eliott, Dean, MD and Hoffman, Richard S., MD and Mamalis, Nick, MD and Miller, Kevin M., MD and Wykoff, Charles C., MD, PhD
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2017, Volume 124, Issue 5, pp. 583 - 595
Ophthalmology | Medical colleges | Vasculitis | Antibacterial agents | Consulting services
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Thresholds for Initiating Treatment of Eyes with Diabetic Macular Edema and Good Vision: Consideration of DRCR.Net Protocol V Results
by Wykoff, Charles C
Ophthalmology retina, ISSN 2468-6530, 11/2019, Volume 3, Issue 11, pp. 917 - 919
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Neutralization of Vascular Endothelial Growth Factor Slows Progression of Retinal Nonperfusion in Patients with Diabetic Macular Edema
by Campochiaro, Peter A., MD and Wykoff, Charles C., MD, PhD and Shapiro, Howard, PhD and Rubio, Roman G., MD and Ehrlich, Jason S., MD, PhD
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 9, pp. 1783 - 1789
Ophthalmology | retinal nonperfusion | central retinal vein occlusion | ETDRS | VEGF | retinal vein occlusion | Abbreviations and Acronyms | RVO | RBZ | ranibizumab | branch retinal vein occlusion | RNP | BRVO | Early Treatment Diabetic Retinopathy Study | vascular endothelial growth factor | CRVO | disc area | DME | diabetic macular edema | Life Sciences & Biomedicine | Science & Technology | Diabetic Retinopathy - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Disease Progression | Retinal Vein Occlusion - complications | Macular Edema - etiology | Regional Blood Flow - drug effects | Retinal Vein Occlusion - drug therapy | Macular Edema - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Retrospective Studies | Dropsy | Edema | Care and treatment | Diabetes | Vascular endothelial growth factor | Consulting services | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Innovation in Neovascular Age-Related Macular Degeneration: Consideration of Brolucizumab, Abicipar, and the Port Delivery System
by Wykoff, Charles C and Wykoff, Charles C and Hariprasad, Seenu M and Hariprasad, Seenu M and Zhou, Brenda and Zhou, Brenda
Ophthalmic surgery, lasers & imaging retina, ISSN 2325-8160, 12/2018, Volume 49, Issue 12, pp. 913 - 917
Ophthalmology | Life Sciences & Biomedicine | Surgery | Science & Technology
Journal Article
Details down arrow
12. Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR protocol T
by Wykoff, Charles C and Hariprasad, Seenu M
Ophthalmic surgery, lasers & imaging retina, ISSN 2325-8160, 03/2015, Volume 46, Issue 3, pp. 302 - 305
Ophthalmology | Life Sciences & Biomedicine | Surgery | Science & Technology | Diabetic Retinopathy - drug therapy | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Clinical Protocols | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Diabetic Retinopathy - physiopathology | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Randomized Controlled Trials as Topic | Macular Edema - physiopathology | Macular Edema - drug therapy | Receptors, Vascular Endothelial Growth Factor - adverse effects | Therapeutic Equivalency
Journal Article
Details down arrow
13. Full Text Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study
by Fan, Wenying and Wang, Kang and Ghasemi Falavarjani, Khalil and Sagong, Min and Uji, Akihito and Ip, Michael and Wykoff, Charles C and Brown, David M and van Hemert, Jano and Sadda, SriniVas R
American journal of ophthalmology, ISSN 0002-9394, 08/2017, Volume 180, pp. 110 - 116
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Diabetic Retinopathy - drug therapy | Prospective Studies | Capillaries - pathology | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Male | Ranibizumab - therapeutic use | Ischemia - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Ischemia - diagnosis | Diabetic Retinopathy - physiopathology | Retinal Vessels - pathology | Diabetic Retinopathy - diagnosis | Macular Edema - physiopathology | Macular Edema - diagnosis | Macular Edema - drug therapy | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Visual Acuity - physiology | Fluorescein Angiography | Dropsy | Edema | Angiography | Fluorescein | Studies | Photography | Diabetic retinopathy | Medical imaging | Ischemia | Tomography | Retina | Diabetes | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy A Secondary Analysis of a Randomized Clinical Trial
by Alagorie, Ahmed Roshdy and Nittala, Muneeswar Gupta and Velaga, Swetha and Zhou, Brenda and Rusakevich, Alexander M and Wykoff, Charles C and Sadda, SriniVas R
JAMA ophthalmology, ISSN 2168-6165, 08/2020, Volume 138, Issue 8, pp. 851 - 857
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Retinal Neovascularization - diagnosis | Diabetic Retinopathy - drug therapy | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Follow-Up Studies | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Slit Lamp Microscopy | Treatment Outcome | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - physiopathology | Retinal Vessels - pathology | Diabetic Retinopathy - diagnosis | Angiogenesis Inhibitors - therapeutic use | Retinal Vessels - diagnostic imaging | Adult | Female | Retinal Neovascularization - drug therapy | Retinal Neovascularization - physiopathology | Visual Acuity - physiology | Fluorescein Angiography | Edema | Diabetic retinopathy | Medical imaging | Retinopathy | Segmentation | Angiography | Diabetes mellitus | Clinical trials | Tomography | Diabetes | Vascular endothelial growth factor
Journal Article
Details down arrow